Prevalence of the Japanese high bleeding risk criteria and its prognostic significance for fatal bleeding in patients with acute myocardial infarction-Reference-Cited by-同舟云学术

Prevalence of the Japanese high bleeding risk criteria and its prognostic significance for fatal bleeding in patients with acute myocardial infarction

Published:2021-03-20 Issue:10 Volume:36 Page:1484-1495
ISSN:0910-8327
Container-title:Heart and Vessels
language:en
Short-container-title:Heart Vessels

Author:

Sotomi Yohei,Hikoso Shungo^ORCID,Nakatani Daisaku,Suna Shinichiro,Dohi Tomoharu,Mizuno Hiroya,Okada Katsuki,Kida Hirota,Oeun Bolrathanak,Sunaga Akihiro,Sato Taiki,Kitamura Tetsuhisa,Sakata Yasuhiko,Sato Hiroshi,Hori Masatsugu,Komuro Issei,Sakata Yasushi,

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00380-021-01836-9.pdf

Reference33 articles.

1. Kobayashi T, Sotomi Y, Suzuki S, Suwannasom P, Nakatani S, Morino Y, Ako J, Kozuma K, Hirayama A, Sakata Y, Higuchi Y (2020) Five-year clinical efficacy and safety of contemporary thin-strut biodegradable polymer versus durable polymer drug-eluting stents: a systematic review and meta-analysis of 9 randomized controlled trials. Cardiovasc Interv Ther 35:250–258

2. Urban P, Meredith IT, Abizaid A, Pocock SJ, Carrie D, Naber C, Lipiecki J, Richardt G, Iniguez A, Brunel P, Valdes-Chavarri M, Garot P, Talwar S, Berland J, Abdellaoui M, Eberli F, Oldroyd K, Zambahari R, Gregson J, Greene S, Stoll HP, Morice MC, Investigators LF (2015) Polymer-free drug-coated coronary stents in patients at high bleeding risk. N Engl J Med 373:2038–2047

3. Varenne O, Cook S, Sideris G, Kedev S, Cuisset T, Carrie D, Hovasse T, Garot P, El Mahmoud R, Spaulding C, Helft G, Diaz Fernandez JF, Brugaletta S, Pinar-Bermudez E, Mauri Ferre J, Commeau P, Teiger E, Bogaerts K, Sabate M, Morice MC, Sinnaeve PR, investigators S (2018) Drug-eluting stents in elderly patients with coronary artery disease (SENIOR): a randomised single-blind trial. Lancet 391:41–50

4. Iglesias JF, Muller O, Heg D, Roffi M, Kurz DJ, Moarof I, Weilenmann D, Kaiser C, Tapponnier M, Stortecky S, Losdat S, Eeckhout E, Valgimigli M, Odutayo A, Zwahlen M, Juni P, Windecker S, Pilgrim T (2019) Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in patients with ST-segment elevation myocardial infarction (BIOSTEMI): a single-blind, prospective, randomised superiority trial. Lancet 394:1243–1253

5. Chhatriwalla AK, Amin AP, Kennedy KF, House JA, Cohen DJ, Rao SV, Messenger JC, Marso SP, National Cardiovascular Data R (2013) Association between bleeding events and in-hospital mortality after percutaneous coronary intervention. JAMA 309:1022–1029

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Prognostic Impact of In-Hospital Major Bleeding and Recurrence of Myocardial Infarction during Acute Phase after Percutaneous Coronary Intervention for Acute Myocardial Infarction;Journal of Atherosclerosis and Thrombosis;2024-02-01

2. Characteristics and outcomes in elderly patients with non-valvular atrial fibrillation and high bleeding risk: subanalysis of the J-RHYTHM Registry;Heart and Vessels;2023-12-16

3. Diagnostic ability of Japanese version of high bleeding risk criteria for ischemic outcomes in patients with acute myocardial infarction;Heart and Vessels;2023-08-20

4. P2Y12 inhibitor monotherapy after complex percutaneous coronary intervention: a systematic review and meta-analysis of randomized clinical trials;Scientific Reports;2023-08-03

5. Impact of the Japanese Version of High Bleeding Risk Criteria on Clinical Outcomes in Patients with ST-segment Elevation Myocardial Infarction;Journal of Atherosclerosis and Thrombosis;2023